 | • レポートコード：MRC2012B0191 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、慢性肝疾患治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。慢性肝疾患治療薬の種類別市場規模（化学療法薬、標的療法、ワクチン、抗ウイルス薬、免疫グロブリン、コルチコステロイド、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Astellas Pharma、Sanofi、GlaxoSmithKline、Bristol-Myers Squibb、Novartis、Gilead Sciences、Takeda Pharmaceutical、Merck、F. Hoffmann-La Roche、Pfizer、Dicerna Pharmaceuticals、MAX BioPharma、Bausch Health、Endo International、Protagonist Therapeutics、Theratechnologies、Provectus Biopharmaceuticals、Alnylam Pharmaceuticals、 ・地域別グローバル市場分析 2015年-2020年 ・慢性肝疾患治療薬の北米市場（アメリカ、カナダ、メキシコ） ・慢性肝疾患治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・慢性肝疾患治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・慢性肝疾患治療薬の南米市場（ブラジル、アルゼンチン） ・慢性肝疾患治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学療法薬、標的療法、ワクチン、抗ウイルス薬、免疫グロブリン、コルチコステロイド、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Chronic Liver Diseases Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Chronic Liver Diseases Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Chronic Liver Diseases Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Chronic Liver Diseases Therapeutics market has been segmented into:
Chemotherapy Drugs
Targeted Therapy
Vaccines
Antiviral Drugs
Immunoglobulins
Corticosteroids
Others
By Application, Chronic Liver Diseases Therapeutics has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Chronic Liver Diseases Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Chronic Liver Diseases Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Chronic Liver Diseases Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Chronic Liver Diseases Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Chronic Liver Diseases Therapeutics Market Share Analysis
Chronic Liver Diseases Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Chronic Liver Diseases Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Chronic Liver Diseases Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Chronic Liver Diseases Therapeutics are:
Astellas Pharma
Sanofi
GlaxoSmithKline
Bristol-Myers Squibb
Novartis
Gilead Sciences
Takeda Pharmaceutical
Merck
F. Hoffmann-La Roche
Pfizer
Dicerna Pharmaceuticals
MAX BioPharma
Bausch Health
Endo International
Protagonist Therapeutics
Theratechnologies
Provectus Biopharmaceuticals
Alnylam Pharmaceuticals
Among other players domestic and global, Chronic Liver Diseases Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Chronic Liver Diseases Therapeutics Market Overview
1.1 Product Overview and Scope of Chronic Liver Diseases Therapeutics
1.2 Classification of Chronic Liver Diseases Therapeutics by Type
1.2.1 Global Chronic Liver Diseases Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type in 2019
1.2.3 Chemotherapy Drugs
1.2.4 Targeted Therapy
1.2.5 Vaccines
1.2.6 Antiviral Drugs
1.2.7 Immunoglobulins
1.2.8 Corticosteroids
1.2.9 Others
1.3 Global Chronic Liver Diseases Therapeutics Market by Application
1.3.1 Overview: Global Chronic Liver Diseases Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Chronic Liver Diseases Therapeutics Market by Regions
1.4.1 Global Chronic Liver Diseases Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Chronic Liver Diseases Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Chronic Liver Diseases Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Chronic Liver Diseases Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chronic Liver Diseases Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Chronic Liver Diseases Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chronic Liver Diseases Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma SWOT Analysis
2.1.4 Astellas Pharma Product and Services
2.1.5 Astellas Pharma Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline SWOT Analysis
2.3.4 GlaxoSmithKline Product and Services
2.3.5 GlaxoSmithKline Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb SWOT Analysis
2.4.4 Bristol-Myers Squibb Product and Services
2.4.5 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Gilead Sciences
2.6.1 Gilead Sciences Details
2.6.2 Gilead Sciences Major Business
2.6.3 Gilead Sciences Product and Services
2.6.4 Gilead Sciences Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda Pharmaceutical
2.7.1 Takeda Pharmaceutical Details
2.7.2 Takeda Pharmaceutical Major Business
2.7.3 Takeda Pharmaceutical Product and Services
2.7.4 Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Product and Services
2.8.4 Merck Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 F. Hoffmann-La Roche
2.9.1 F. Hoffmann-La Roche Details
2.9.2 F. Hoffmann-La Roche Major Business
2.9.3 F. Hoffmann-La Roche Product and Services
2.9.4 F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Product and Services
2.10.4 Pfizer Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Dicerna Pharmaceuticals
2.11.1 Dicerna Pharmaceuticals Details
2.11.2 Dicerna Pharmaceuticals Major Business
2.11.3 Dicerna Pharmaceuticals Product and Services
2.11.4 Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 MAX BioPharma
2.12.1 MAX BioPharma Details
2.12.2 MAX BioPharma Major Business
2.12.3 MAX BioPharma Product and Services
2.12.4 MAX BioPharma Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Bausch Health
2.13.1 Bausch Health Details
2.13.2 Bausch Health Major Business
2.13.3 Bausch Health Product and Services
2.13.4 Bausch Health Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Endo International
2.14.1 Endo International Details
2.14.2 Endo International Major Business
2.14.3 Endo International Product and Services
2.14.4 Endo International Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Protagonist Therapeutics
2.15.1 Protagonist Therapeutics Details
2.15.2 Protagonist Therapeutics Major Business
2.15.3 Protagonist Therapeutics Product and Services
2.15.4 Protagonist Therapeutics Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.16 Theratechnologies
2.16.1 Theratechnologies Details
2.16.2 Theratechnologies Major Business
2.16.3 Theratechnologies Product and Services
2.16.4 Theratechnologies Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Provectus Biopharmaceuticals
2.17.1 Provectus Biopharmaceuticals Details
2.17.2 Provectus Biopharmaceuticals Major Business
2.17.3 Provectus Biopharmaceuticals Product and Services
2.17.4 Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.18 Alnylam Pharmaceuticals
2.18.1 Alnylam Pharmaceuticals Details
2.18.2 Alnylam Pharmaceuticals Major Business
2.18.3 Alnylam Pharmaceuticals Product and Services
2.18.3 Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Chronic Liver Diseases Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Chronic Liver Diseases Therapeutics Players Market Share
3.2.2 Top 10 Chronic Liver Diseases Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Chronic Liver Diseases Therapeutics Revenue and Market Share by Regions
4.2 North America Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Chronic Liver Diseases Therapeutics Revenue by Countries
5.1 North America Chronic Liver Diseases Therapeutics Revenue by Countries (2015-2020)
5.2 USA Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Chronic Liver Diseases Therapeutics Revenue by Countries
6.1 Europe Chronic Liver Diseases Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Chronic Liver Diseases Therapeutics Revenue by Countries
7.1 Asia-Pacific Chronic Liver Diseases Therapeutics Revenue by Countries (2015-2020)
7.2 China Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Chronic Liver Diseases Therapeutics Revenue by Countries
8.1 South America Chronic Liver Diseases Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Chronic Liver Diseases Therapeutics by Countries
9.1 Middle East & Africa Chronic Liver Diseases Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Chronic Liver Diseases Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Chronic Liver Diseases Therapeutics Market Forecast by Type (2019-2024)
10.3 Chemotherapy Drugs Revenue Growth Rate (2015-2025)
10.4 Targeted Therapy Revenue Growth Rate (2015-2025)
10.5 Vaccines Revenue Growth Rate (2015-2025)
10.6 Antiviral Drugs Revenue Growth Rate (2015-2025)
10.7 Immunoglobulins Revenue Growth Rate (2015-2025)
10.8 Corticosteroids Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Chronic Liver Diseases Therapeutics Market Segment by Application
11.1 Global Chronic Liver Diseases Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Chronic Liver Diseases Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Chronic Liver Diseases Therapeutics Market Size Forecast (2021-2025)
12.1 Global Chronic Liver Diseases Therapeutics Market Size Forecast (2021-2025)
12.2 Global Chronic Liver Diseases Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Chronic Liver Diseases Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Chronic Liver Diseases Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Chronic Liver Diseases Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Chronic Liver Diseases Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Chronic Liver Diseases Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Chronic Liver Diseases Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Chronic Liver Diseases Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Chronic Liver Diseases Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Chronic Liver Diseases Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Chronic Liver Diseases Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Astellas Pharma Corporate Information, Location and Competitors
Table 7. Astellas Pharma Chronic Liver Diseases Therapeutics Major Business
Table 8. Astellas Pharma Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 9. Astellas Pharma SWOT Analysis
Table 10. Astellas Pharma Chronic Liver Diseases Therapeutics Product and Solutions
Table 11. Astellas Pharma Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Sanofi Corporate Information, Location and Competitors
Table 13. Sanofi Chronic Liver Diseases Therapeutics Major Business
Table 14. Sanofi Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2018-2019)
Table 15. Sanofi SWOT Analysis
Table 16. Sanofi Chronic Liver Diseases Therapeutics Product and Solutions
Table 17. Sanofi Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. GlaxoSmithKline Corporate Information, Location and Competitors
Table 19. GlaxoSmithKline Chronic Liver Diseases Therapeutics Major Business
Table 20. GlaxoSmithKline Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 21. GlaxoSmithKline SWOT Analysis
Table 22. GlaxoSmithKline Chronic Liver Diseases Therapeutics Product and Solutions
Table 23. GlaxoSmithKline Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 25. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Major Business
Table 26. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 27. Bristol-Myers Squibb SWOT Analysis
Table 28. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Product and Solutions
Table 29. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Novartis Corporate Information, Location and Competitors
Table 31. Novartis Chronic Liver Diseases Therapeutics Major Business
Table 32. Novartis Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 33. Novartis SWOT Analysis
Table 34. Novartis Chronic Liver Diseases Therapeutics Product and Solutions
Table 35. Novartis Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Gilead Sciences Corporate Information, Location and Competitors
Table 37. Gilead Sciences Chronic Liver Diseases Therapeutics Major Business
Table 38. Gilead Sciences Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 39. Gilead Sciences SWOT Analysis
Table 40. Gilead Sciences Chronic Liver Diseases Therapeutics Product and Solutions
Table 41. Gilead Sciences Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Takeda Pharmaceutical Corporate Information, Location and Competitors
Table 43. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Major Business
Table 44. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 45. Takeda Pharmaceutical SWOT Analysis
Table 46. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Product and Solutions
Table 47. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Merck Corporate Information, Location and Competitors
Table 49. Merck Chronic Liver Diseases Therapeutics Major Business
Table 50. Merck Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 51. Merck SWOT Analysis
Table 52. Merck Chronic Liver Diseases Therapeutics Product and Solutions
Table 53. Merck Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 55. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Major Business
Table 56. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 57. F. Hoffmann-La Roche SWOT Analysis
Table 58. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Product and Solutions
Table 59. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Pfizer Corporate Information, Location and Competitors
Table 61. Pfizer Chronic Liver Diseases Therapeutics Major Business
Table 62. Pfizer Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 63. Pfizer SWOT Analysis
Table 64. Pfizer Chronic Liver Diseases Therapeutics Product and Solutions
Table 65. Pfizer Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Dicerna Pharmaceuticals Corporate Information, Location and Competitors
Table 67. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Major Business
Table 68. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 69. Dicerna Pharmaceuticals SWOT Analysis
Table 70. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Product and Solutions
Table 71. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. MAX BioPharma Corporate Information, Location and Competitors
Table 73. MAX BioPharma Chronic Liver Diseases Therapeutics Major Business
Table 74. MAX BioPharma Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 75. MAX BioPharma SWOT Analysis
Table 76. MAX BioPharma Chronic Liver Diseases Therapeutics Product and Solutions
Table 77. MAX BioPharma Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Bausch Health Corporate Information, Location and Competitors
Table 79. Bausch Health Chronic Liver Diseases Therapeutics Major Business
Table 80. Bausch Health Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 81. Bausch Health SWOT Analysis
Table 82. Bausch Health Chronic Liver Diseases Therapeutics Product and Solutions
Table 83. Bausch Health Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Endo International Corporate Information, Location and Competitors
Table 85. Endo International Chronic Liver Diseases Therapeutics Major Business
Table 86. Endo International Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 87. Endo International SWOT Analysis
Table 88. Endo International Chronic Liver Diseases Therapeutics Product and Solutions
Table 89. Endo International Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Protagonist Therapeutics Corporate Information, Location and Competitors
Table 91. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Major Business
Table 92. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 93. Protagonist Therapeutics SWOT Analysis
Table 94. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Product and Solutions
Table 95. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Theratechnologies Corporate Information, Location and Competitors
Table 97. Theratechnologies Chronic Liver Diseases Therapeutics Major Business
Table 98. Theratechnologies Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 99. Theratechnologies SWOT Analysis
Table 100. Theratechnologies Chronic Liver Diseases Therapeutics Product and Solutions
Table 101. Theratechnologies Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Provectus Biopharmaceuticals Corporate Information, Location and Competitors
Table 103. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Major Business
Table 104. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 105. Provectus Biopharmaceuticals SWOT Analysis
Table 106. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Product and Solutions
Table 107. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Type and Application
Table 109. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Major Business
Table 110. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Total Revenue (USD Million) (2017-2018)
Table 111. Alnylam Pharmaceuticals SWOT Analysis
Table 112. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Product and Solutions
Table 113. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Global Chronic Liver Diseases Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 115. Global Chronic Liver Diseases Therapeutics Revenue Share by Players (2015-2020)
Table 116. Global Chronic Liver Diseases Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 117. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Regions (2015-2020)
Table 118. North America Chronic Liver Diseases Therapeutics Revenue by Countries (2015-2020)
Table 119. North America Chronic Liver Diseases Therapeutics Revenue Market Share by Countries (2015-2020)
Table 120. Europe Chronic Liver Diseases Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 121. Asia-Pacific Chronic Liver Diseases Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 122. South America Chronic Liver Diseases Therapeutics Revenue by Countries (2015-2020)
Table 123. South America Chronic Liver Diseases Therapeutics Revenue Market Share by Countries (2015-2020)
Table 124. Middle East and Africa Chronic Liver Diseases Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 125. Middle East and Africa Chronic Liver Diseases Therapeutics Revenue Market Share by Countries (2015-2020)
Table 126. Global Chronic Liver Diseases Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 127. Global Chronic Liver Diseases Therapeutics Revenue Share by Type (2015-2020)
Table 128. Global Chronic Liver Diseases Therapeutics Revenue Forecast by Type (2021-2025)
Table 129. Global Chronic Liver Diseases Therapeutics Revenue by Application (2015-2020)
Table 130. Global Chronic Liver Diseases Therapeutics Revenue Share by Application (2015-2020)
Table 131. Global Chronic Liver Diseases Therapeutics Revenue Forecast by Application (2021-2025)
Table 132. Global Chronic Liver Diseases Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Chronic Liver Diseases Therapeutics Picture
Figure 2. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type in 2019
Figure 3. Chemotherapy Drugs Picture
Figure 4. Targeted Therapy Picture
Figure 5. Vaccines Picture
Figure 6. Antiviral Drugs Picture
Figure 7. Immunoglobulins Picture
Figure 8. Corticosteroids Picture
Figure 9. Others Picture
Figure 10. Chronic Liver Diseases Therapeutics Revenue Market Share by Application in 2019
Figure 11. Hospital Pharmacies Picture
Figure 12. Retail Pharmacies Picture
Figure 13. Online Pharmacies Picture
Figure 14. Global Chronic Liver Diseases Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Chronic Liver Diseases Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Chronic Liver Diseases Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Chronic Liver Diseases Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Chronic Liver Diseases Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Chronic Liver Diseases Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Chronic Liver Diseases Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Chronic Liver Diseases Therapeutics Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Chronic Liver Diseases Therapeutics Revenue Market Share in 2019
Figure 23. Global Top 10 Players Chronic Liver Diseases Therapeutics Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Chronic Liver Diseases Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 27. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Regions in 2018
Figure 28. North America Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Europe Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. South America Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. North America Chronic Liver Diseases Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 34. North America Chronic Liver Diseases Therapeutics Revenue Market Share by Countries in 2019
Figure 35. USA Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Canada Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. Europe Chronic Liver Diseases Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Chronic Liver Diseases Therapeutics Revenue Market Share by Countries in 2019
Figure 40. Germany Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. UK Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. France Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Russia Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Italy Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Chronic Liver Diseases Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Chronic Liver Diseases Therapeutics Revenue Market Share by Countries in 2019
Figure 47. China Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Japan Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Korea Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. India Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. South America Chronic Liver Diseases Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 53. South America Chronic Liver Diseases Therapeutics Revenue Market Share by Countries in 2019
Figure 54. Brazil Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Chronic Liver Diseases Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Chronic Liver Diseases Therapeutics Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. UAE Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Chronic Liver Diseases Therapeutics Revenue and Growth Rate (2015-2020)
Figure 62. Global Chronic Liver Diseases Therapeutics Revenue Share by Type (2015-2020)
Figure 63. Global Chronic Liver Diseases Therapeutics Revenue Share by Type in 2019
Figure 64. Global Chronic Liver Diseases Therapeutics Market Share Forecast by Type (2021-2025)
Figure 65. Global Chemotherapy Drugs Revenue Growth Rate (2015-2020)
Figure 66. Global Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 67. Global Vaccines Revenue Growth Rate (2015-2020)
Figure 68. Global Antiviral Drugs Revenue Growth Rate (2015-2020)
Figure 69. Global Immunoglobulins Revenue Growth Rate (2015-2020)
Figure 70. Global Corticosteroids Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Chronic Liver Diseases Therapeutics Revenue Share by Application (2015-2020)
Figure 73. Global Chronic Liver Diseases Therapeutics Revenue Share by Application in 2019
Figure 74. Global Chronic Liver Diseases Therapeutics Market Share Forecast by Application (2021-2025)
Figure 75. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 76. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 77. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 78. Global Chronic Liver Diseases Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Chronic Liver Diseases Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Chronic Liver Diseases Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Chronic Liver Diseases Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Europe Chronic Liver Diseases Therapeutics Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Chronic Liver Diseases Therapeutics Revenue Market Forecast (2021-2025)
Figure 84. South America Chronic Liver Diseases Therapeutics Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Chronic Liver Diseases Therapeutics Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
慢性肝疾患治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Liver Diseases Therapeutics Market The global Chronic Liver Diseases Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…- 肝疾患治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Liver Diseases Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Liver Disea…
- 慢性疾患管理の世界市場（～2026年） Chronic Disease Management which was also known as enhanced primary care earlier is the ongoing care and support which help in managing the health care of patient suffering with chronic disease such as asthma, cancer, diabetes, cardiovascular diseases, stroke, etc. It also require visits and support…
- 慢性肺疾患治療の世界市場（～2026年） Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in r…
- 非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …